A double-blind placebo-controlled trial of L-threonine in amyotrophic lateral sclerosis
- PMID: 1313078
- DOI: 10.1007/BF00862977
A double-blind placebo-controlled trial of L-threonine in amyotrophic lateral sclerosis
Abstract
Fifteen patients with the unequivocal diagnosis of amyotrophic lateral sclerosis (ALS) completed a 1-year randomized double-blind placebo-controlled trial of L-threonine (2 g daily). During the study, patients in the placebo group showed a decline in functional status consistent with the natural history of ALS, which was not statistically different from outcome in the patients in the L-threonine group.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Miscellaneous